Ketosis-prone diabetes
A diabetes form with DKA and possible beta cell recovery.
Ketosis-prone diabetes (KPD) is an intermediate form of diabetes that combines characteristics of both type 1 and type 2 diabetes. It is defined by recurrent diabetic ketoacidosis (DKA) with subsequent beta cell recovery, distinguishing it from classic type 1 diabetes or stress-induced DKA. KPD typically occurs later in life and can involve the reclamation of beta cell function, a trait more common in type 2 diabetes. KPD is distinct from latent autoimmune diabetes of adults (LADA) and is classified using the Aβ system, which assesses the presence or absence of β-cell autoantibodies and β-cell functional reserve.
- field
- Medicine (Endocrinology)
- known_for
- Intermediate diabetes with DKA and potential beta cell recovery
- classification_system
- Aβ system (A+ or A−; β+ or β−)
- key_feature
- Diabetic ketoacidosis (DKA) at presentation
- subtypes
- Four forms based on autoantibodies and beta cell reserve
Lore & Background
Ketosis-prone diabetes (KPD) is an intermediate form of diabetes that presents with diabetic ketoacidosis (DKA), similar to type 1 diabetes, but occurs later in life and can involve the reclamation of beta cell function, a characteristic of type 2 diabetes. It is distinct from latent autoimmune diabetes of adults (LADA), which typically does not involve DKA and may show only temporary or partial beta cell recovery. KPD is diagnosed by recurrent DKA episodes with evidence of beta cell recovery, not by a single DKA event alone.
Reader's Guide
KPD is classified into four subtypes using the Aβ system, which evaluates the presence or absence of β-cell autoantibodies (A+ or A−) and β-cell functional reserve (β+ or β−). This system has been found to have the highest accuracy and predictive value among classification methods. Management involves acutely treating DKA with fluid repletion, electrolyte repletion, and insulin, followed by identification of the KPD subtype using autoantibody testing and C-peptide levels. Long-term management includes insulin therapy and diabetic education, with other anti-glycemic agents added only if glucose levels rise on effective insulin therapy. Prognosis varies: patients with beta cell reserve at onset (β+ subtype) have about a 50% chance of regaining full beta cell function and becoming insulin independent, though most KPD patients remain insulin dependent. Proper glycemic control is important for protecting beta cell function and improving outcomes.
Did You Know?
- KPD is diagnosed by recurrent DKA with beta cell recovery, not by a single episode of ketoacidosis alone.
- The Aβ classification system for KPD uses autoantibodies such as GAD65, ZnT8, IA-2, and HLA class II type 1 diabetes susceptibility alleles.
- Patients with the β+ subtype of KPD may regain beta cell function and become insulin independent, though the likelihood varies by study and 'full beta cell function' is not consistently defined.
- KPD is distinct from LADA, as LADA typically does not involve DKA and may show only temporary or partial beta cell recovery.
Frequently Asked Questions
What is Ketosis-prone diabetes?
Ketosis-prone diabetes is an intermediate diabetic phenotype that blends traits of both type 1 and type 2 diabetes. Its defining hallmark is presenting with diabetic ketoacidosis while still retaining enough functional beta cells to recover afterward.
How is Ketosis-prone diabetes classified?
It is sorted using the Aβ system, which looks at whether β-cell autoantibodies are present or absent and whether residual beta cell reserve remains. This yields four distinct subtypes (A+β+, A+β−, A−β+, A−β−) that help clinicians tailor management.
What makes Ketosis-prone diabetes different from classic type 1 diabetes?
Unlike classic type 1, where beta cell destruction is permanent, KPD patients can regain meaningful insulin-producing capacity after an acute DKA episode. This recovery trait aligns it more closely with type 2 biology, even though the initial presentation mimics type 1.
When does Ketosis-prone diabetes typically show up?
KPD generally manifests later in life than childhood-onset type 1 diabetes, often in adults who would otherwise be expected to develop type 2. The delayed onset combined with the DKA presentation is one of the clues that separates it from both classic forms.
Why is Ketosis-prone diabetes important to the endocrinology community?
It challenges the traditional binary of type 1 versus type 2 by demonstrating that beta cell function is not all-or-nothing. Recognizing KPD as its own entity prevents misdiagnosis, avoids unnecessary lifelong insulin dependence, and opens the door to therapies aimed at preserving or restoring residual beta cell mass.
More in Aging-associated diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record